These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 38681125)

  • 21. The Role of Fusobacterium nucleatum in Colorectal Carcinogenesis.
    Datorre JG; de Carvalho AC; Guimarães DP; Reis RM
    Pathobiology; 2021; 88(2):127-140. PubMed ID: 33291114
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Ye X; Wang R; Bhattacharya R; Boulbes DR; Fan F; Xia L; Adoni H; Ajami NJ; Wong MC; Smith DP; Petrosino JF; Venable S; Qiao W; Baladandayuthapani V; Maru D; Ellis LM
    Cancer Prev Res (Phila); 2017 Jul; 10(7):398-409. PubMed ID: 28483840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opportunistic detection of Fusobacterium nucleatum as a marker for the early gut microbial dysbiosis.
    Huh JW; Roh TY
    BMC Microbiol; 2020 Jul; 20(1):208. PubMed ID: 32660414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sodium butyrate modulates gut microbiota and immune response in colorectal cancer liver metastatic mice.
    Ma X; Zhou Z; Zhang X; Fan M; Hong Y; Feng Y; Dong Q; Diao H; Wang G
    Cell Biol Toxicol; 2020 Oct; 36(5):509-515. PubMed ID: 32172331
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Gethings-Behncke C; Coleman HG; Jordao HWT; Longley DB; Crawford N; Murray LJ; Kunzmann AT
    Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):539-548. PubMed ID: 31915144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fusobacterium nucleatum and colorectal cancer: A mechanistic overview.
    Hashemi Goradel N; Heidarzadeh S; Jahangiri S; Farhood B; Mortezaee K; Khanlarkhani N; Negahdari B
    J Cell Physiol; 2019 Mar; 234(3):2337-2344. PubMed ID: 30191984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fusobacterium nucleatum-triggered neutrophil extracellular traps facilitate colorectal carcinoma progression.
    Kong X; Zhang Y; Xiang L; You Y; Duan Y; Zhao Y; Li S; Wu R; Zhang J; Zhou L; Duan L
    J Exp Clin Cancer Res; 2023 Sep; 42(1):236. PubMed ID: 37684625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fusobacterium nucleatum infection modulates the transcriptome and epigenome of HCT116 colorectal cancer cells in an oxygen-dependent manner.
    Udayasuryan B; Zhou Z; Ahmad RN; Sobol P; Deng C; Nguyen TTD; Kodikalla S; Morrison R; Goswami I; Slade DJ; Verbridge SS; Lu C
    Commun Biol; 2024 May; 7(1):551. PubMed ID: 38720110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of Fusobacterium nucleatum in stool and colonic tissues from Norwegian colorectal cancer patients.
    Tunsjø HS; Gundersen G; Rangnes F; Noone JC; Endres A; Bemanian V
    Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1367-1376. PubMed ID: 31025134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ANGPTL4-Mediated Promotion of Glycolysis Facilitates the Colonization of
    Zheng X; Liu R; Zhou C; Yu H; Luo W; Zhu J; Liu J; Zhang Z; Xie N; Peng X; Xu X; Cheng L; Yuan Q; Huang C; Zhou X
    Cancer Res; 2021 Dec; 81(24):6157-6170. PubMed ID: 34645607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role of Fecal
    Liu K; Yang X; Zeng M; Yuan Y; Sun J; He P; Sun J; Xie Q; Chang X; Zhang S; Chen X; Cai L; Xie Y; Jiao X
    Dis Markers; 2021; 2021():1171239. PubMed ID: 34853619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer.
    Jiang SS; Xie YL; Xiao XY; Kang ZR; Lin XL; Zhang L; Li CS; Qian Y; Xu PP; Leng XX; Wang LW; Tu SP; Zhong M; Zhao G; Chen JX; Wang Z; Liu Q; Hong J; Chen HY; Chen YX; Fang JY
    Cell Host Microbe; 2023 May; 31(5):781-797.e9. PubMed ID: 37130518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Norepinephrine may promote the progression of
    Du X; Tang Z; Yan L; Zhang L; Zheng Q; Zeng X; Hu Q; Tian Q; Liang L; Zhao X; Li J; Zhao M; Fu X
    Virulence; 2024 Dec; 15(1):2350904. PubMed ID: 38725098
    [No Abstract]   [Full Text] [Related]  

  • 34.
    Wang N; Zhang L; Leng XX; Xie YL; Kang ZR; Zhao LC; Song LH; Zhou CB; Fang JY
    Gut Microbes; 2024; 16(1):2333790. PubMed ID: 38533566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of metronidazole on colorectal cancer occurrence and colorectal cancer liver metastases by regulating Fusobacterium nucleatum in mice.
    Wang M; Li Y; Yang X; Liu Z; Wang K; Gong D; Li J
    Immun Inflamm Dis; 2023 Nov; 11(11):e1067. PubMed ID: 38018574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Both endogenous and exogenous miR-139-5p inhibit Fusobacterium nucleatum-related colorectal cancer development.
    Zhao Y; Tao Q; Li S; Zheng P; Liu J; Liang X
    Eur J Pharmacol; 2020 Dec; 888():173459. PubMed ID: 32768506
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Chen S; Su T; Zhang Y; Lee A; He J; Ge Q; Wang L; Si J; Zhuo W; Wang L
    Gut Microbes; 2020 May; 11(3):511-525. PubMed ID: 31910722
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Hussan H; Clinton SK; Roberts K; Bailey MT
    World J Gastroenterol; 2017 Dec; 23(48):8626-8650. PubMed ID: 29358871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population.
    Yamaoka Y; Suehiro Y; Hashimoto S; Hoshida T; Fujimoto M; Watanabe M; Imanaga D; Sakai K; Matsumoto T; Nishioka M; Takami T; Suzuki N; Hazama S; Nagano H; Sakaida I; Yamasaki T
    J Gastroenterol; 2018 Apr; 53(4):517-524. PubMed ID: 28823057
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Kong C; Yan X; Zhu Y; Zhu H; Luo Y; Liu P; Ferrandon S; Kalady MF; Gao R; He J; Yin F; Qu X; Zheng J; Gao Y; Wei Q; Ma Y; Liu JY; Qin H
    Cancer Res; 2021 Sep; 81(17):4485-4498. PubMed ID: 34162680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.